* We recommend a score >= 0.08 for meaningful Gene-Disease associations

GeneID Gene_Symbol DisGeNet_diseaseID Disease_name DisGeNet score DisGeNet_sourceDB
3717JAK2C0032463Polycythemia Vera0.907396798652064BEFREE;CTD_human;GAD;LHGDN;MGD;ORPHANET;UNIPROT
3717JAK2C0027022Myeloproliferative disease0.64BEFREE;CTD_human;GAD;HPO;LHGDN
3717JAK2C0040028Thrombocythemia, Essential0.632640290938448BEFREE;CTD_human;GAD;LHGDN;ORPHANET
3717JAK2C0856761Budd-Chiari Syndrome0.616207201536949BEFREE;CTD_human;GAD;HPO;LHGDN;ORPHANET
3717JAK2C0026987Myelofibrosis0.509395765910802BEFREE;HPO;MGD;ORPHANET
3717JAK2C0023467Leukemia, Myelocytic, Acute0.445269140422645BEFREE;CTD_human;GAD;LHGDN;UNIPROT
3717JAK2C0836924Thrombocytosis0.443397210090466BEFREE;CTD_human;GAD;HPO;LHGDN
3717JAK2C0042487Venous Thrombosis0.440467760021763CTD_human;GAD;HPO;LHGDN
3717JAK2C0040038Thromboembolism0.402732912464814CTD_human;HPO;LHGDN
3717JAK2C3281125THROMBOCYTHEMIA 30.4ORPHANET;UNIPROT
3717JAK2C0001815Primary Myelofibrosis0.381891422860773BEFREE;CTD_human;GAD;LHGDN
3717JAK2C3277671THROMBOCYTHEMIA 10.28MGD;ORPHANET
3717JAK2C0023893Liver Cirrhosis, Experimental0.28CTD_human;RGD
3717JAK2C0027051Myocardial Infarction0.28HPO;RGD
3717JAK2C0023418leukemia0.226892835366626BEFREE;CTD_human;GAD;LHGDN
3717JAK2C3463824MYELODYSPLASTIC SYNDROME0.226776165674683BEFREE;GAD;HPO;LHGDN
3717JAK2C0032461Polycythemia0.222599521133841BEFREE;CTD_human;GAD;LHGDN
3717JAK2C0023518Leukocytosis0.215419822964305GAD;HPO;LHGDN
3717JAK2C0009324Ulcerative Colitis0.207011871320281BEFREE;CTD_human;GAD
3717JAK2C0040034Thrombocytopenia0.205465824929628HPO;LHGDN
3717JAK2C0032962Pregnancy Complications0.205414667772315BEFREE;CTD_human;GAD;LHGDN
3717JAK2C0085669Acute leukemia0.203846174978983BEFREE;HPO
3717JAK2C0038002Splenomegaly0.202407028523288GAD;HPO
3717JAK2C0033774Pruritus0.201648360705279BEFREE;HPO
3717JAK2C0020538Hypertensive disease0.200549453568426BEFREE;HPO
3717JAK2C0023890Liver Cirrhosis0.200274726784213BEFREE;HPO
3717JAK2C0149793Amaurosis Fugax0.200274726784213BEFREE;HPO
3717JAK2C0151744Myocardial Ischemia0.200274726784213BEFREE;CTD_human
3717JAK2C0917798Cerebral Ischemia0.200274726784213BEFREE;HPO
3717JAK2C0020541Hypertension, Portal0.2HPO
3717JAK2C0021368Inflammation0.2CTD_human
3717JAK2C2937358Cerebral Hemorrhage0.2HPO
3717JAK2C3275998THROMBOCYTHEMIA 20.2ORPHANET
3717JAK2C4020855Respiratory function loss0.2HPO
3717JAK2C4025187Increased megakaryocyte count0.2HPO
3717JAK2C4280572Acute blood cancer0.2HPO
3717JAK2C0025472Mesenteric Vascular Occlusion0.2CTD_human
3717JAK2C0030554Paresthesia0.2HPO
3717JAK2C0033578Prostatic Neoplasms0.2CTD_human
3717JAK2C0035229Respiratory Insufficiency0.2HPO
3717JAK2C0038990Sweating0.2HPO
3717JAK2C0040264Tinnitus0.2HPO
3717JAK2C0042571Vertigo0.2HPO
3717JAK2C0085307Embolism and Thrombosis0.2HPO
3717JAK2C0086565Liver Dysfunction0.2HPO
3717JAK2C0151529Bleeding time prolonged0.2HPO
3717JAK2C0151766Liver function tests abnormal finding0.2HPO
3717JAK2C0151942Arterial thrombosis0.2HPO
3717JAK2C0231807Dyspnea on exertion0.2HPO
3717JAK2C0232370Florid red complexion (finding)0.2HPO
3717JAK2C0235996Hepatic enzyme increased0.2HPO
3717JAK2C0239935Hematocrit increased0.2HPO
3717JAK2C0392386Decreased platelet count0.2HPO
3717JAK2C0423798Increased tendency to bruise0.2HPO
3717JAK2C0438237Liver enzymes abnormal0.2HPO
3717JAK2C0438717Transaminases increased0.2HPO
3717JAK2C0497247Increase in blood pressure0.2HPO
3717JAK2C0544886Somatic mutation0.2HPO
3717JAK2C0549448Hemoglobin increased0.2HPO
3717JAK2C0553692Brain hemorrhage0.2HPO
3717JAK2C0000737Abdominal Pain0.2HPO
3717JAK2C0000786Spontaneous abortion0.2CTD_human
3717JAK2C0700590Increased sweating0.2HPO
3717JAK2C0002962Angina Pectoris0.2HPO
3717JAK2C0750145vascular disease occlusive0.2HPO
3717JAK2C0003862Arthralgia0.2HPO
3717JAK2C0003962Ascites0.2HPO
3717JAK2C0855742Platelet morphology abnormal0.2HPO
3717JAK2C0857460Increased number of platelets0.2HPO
3717JAK2C0877359Liver function test increased0.2HPO
3717JAK2C0917805Transient Cerebral Ischemia0.2HPO
3717JAK2C0006663Calcinosis0.2CTD_human
3717JAK2C1262477Weight decreased0.2HPO
3717JAK2C0007786Brain Ischemia0.2HPO
3717JAK2C0008031Chest Pain0.2HPO
3717JAK2C1306889Peripheral arterial occlusive disease0.2HPO
3717JAK2C0012833Dizziness0.2HPO
3717JAK2C1401086Peripheral vascular insufficiency0.2HPO
3717JAK2C1458140Bleeding tendency0.2HPO
3717JAK2C0013491Ecchymosis0.2HPO
3717JAK2C0014591Epistaxis0.2HPO
3717JAK2C0014867Esophageal Varices0.2HPO
3717JAK2C0015672Fatigue0.2HPO
3717JAK2C0015967Fever0.2HPO
3717JAK2C0017181Gastrointestinal Hemorrhage0.2HPO
3717JAK2C0017565Gingival Hemorrhage0.2HPO
3717JAK2C1842003Subclinical abnormal liver function tests0.2HPO
3717JAK2C1848701Elevated hepatic transaminases0.2HPO
3717JAK2C1849749Peripheral thrombosis0.2HPO
3717JAK2C1851971Hypoplastic myelodysplasia0.2HPO
3717JAK2C1853237Isolated cases0.2HPO
3717JAK2C0018681Headache0.2HPO
3717JAK2C1853288Increased red blood cell mass0.2HPO
3717JAK2C0018824Heart valve disease0.2CTD_human
3717JAK2C0019209Hepatomegaly0.2HPO
3717JAK2C0020458Hyperhidrosis disorder0.2HPO
3717JAK2C0038454Cerebrovascular accident0.085689394556528BEFREE;GAD;LHGDN;RGD
3717JAK2C0040053Thrombosis0.0849719682744418GAD;LHGDN
3717JAK2C0011881Diabetic Nephropathy0.0802747267842131BEFREE;RGD
3717JAK2C0023892Biliary cirrhosis0.08RGD
3717JAK2C0027055Myocardial Reperfusion Injury0.08RGD
3717JAK2C0035305Retinal Detachment0.08RGD
3717JAK2C0393642Sepsis-Associated Encephalopathy0.08RGD
3717JAK2C0400966Non-alcoholic Fatty Liver Disease0.08RGD
3717JAK2C0993582Arthritis, Experimental0.08RGD
3717JAK2C0007787Transient Ischemic Attack0.08RGD
3717JAK2C0018273Growth Disorders0.08RGD
3717JAK2C0018799Heart Diseases0.08RGD
3717JAK2C0020429Hyperalgesia0.08RGD
3717JAK2C1292778Chronic myeloproliferative disorder0.0744509585217501BEFREE
3717JAK2C0023470Myeloid Leukemia0.0174498103887549BEFREE;GAD;LHGDN
3717JAK2C0013080Down Syndrome0.014935881930509BEFREE;GAD;LHGDN
3717JAK2C0023473Myeloid Leukemia, Chronic0.0144151391167173BEFREE;GAD;LHGDN
3717JAK2C0398623Thrombophilia0.0136835033217186BEFREE;GAD
3717JAK2C1961102Precursor Cell Lymphoblastic Leukemia Lymphoma0.0135254462294481BEFREE;GAD;LHGDN
3717JAK2C0023480Leukemia, Myelomonocytic, Chronic0.0121518123083826BEFREE;GAD;LHGDN
3717JAK2C0010346Crohn Disease0.0115512015826437BEFREE;GAD
3717JAK2C0002893Refractory anemias0.0108804927019424BEFREE;GAD;LHGDN
3717JAK2C0376545Hematologic Neoplasms0.0108580462992642BEFREE;GAD
3717JAK2C1861172Venous Thromboembolism0.00995399803467775GAD;LHGDN
3717JAK2C0019829Hodgkin Disease0.0079383659875454BEFREE;LHGDN
3717JAK2C0023434Chronic Lymphocytic Leukemia0.006839458850693BEFREE;LHGDN
3717JAK2C0079731B-Cell Lymphomas0.0065647320664799BEFREE;LHGDN
3717JAK2C1292772Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative0.0062900052822668BEFREE;LHGDN
3717JAK2C0021390Inflammatory Bowel Diseases0.00623884812495415BEFREE;GAD;LHGDN
3717JAK2C1458155Mammary Neoplasms0.0057405517138406BEFREE;LHGDN
3717JAK2C4022560Splanchnic vein thrombosis0.0056382373992153BEFREE;GAD
3717JAK2C0005699Blast Phase0.0056382373992153BEFREE;GAD
3717JAK2C0023449Acute lymphocytic leukemia0.005494535684262BEFREE
3717JAK2C0030297Pancreatic Neoplasm0.00513994098810175GAD;LHGDN
3717JAK2C0002896Sideroblastic anemia0.00513994098810175GAD;LHGDN
3717JAK2C0038013Ankylosing spondylitis0.0050887838307891BEFREE;GAD
3717JAK2C0024299Lymphoma0.0048795695812059BEFREE;GAD
3717JAK2C0027686Pathologic Neovascularization0.004814057046576GAD
3717JAK2C0042373Vascular Diseases0.004814057046576GAD
3717JAK2C0919532Genomic Instability0.004814057046576GAD
3717JAK2C0007621Neoplastic Cell Transformation0.004814057046576GAD
3717JAK2C0023440Acute Erythroblastic Leukemia0.00410654638587925BEFREE;LHGDN
3717JAK2C0025202melanoma0.00383181960166615BEFREE;LHGDN
3717JAK2C0026764Multiple Myeloma0.00355709281745305BEFREE;LHGDN
3717JAK2C0221013Mastocytosis, Systemic0.00355709281745305BEFREE;LHGDN
3717JAK2C1292769Precursor B-cell lymphoblastic leukemia0.0032967214105572BEFREE
3717JAK2C0349639Juvenile Myelomonocytic Leukemia0.00328236603323995BEFREE;LHGDN
3717JAK2C0006142Malignant neoplasm of breast0.0030219946263441BEFREE
3717JAK2C0600433Activated Protein C Resistance0.00300763924902685BEFREE;LHGDN
3717JAK2C0004153Atherosclerosis0.00300763924902685BEFREE;LHGDN
3717JAK2C0007134Renal Cell Carcinoma0.00300763924902685BEFREE;LHGDN
3717JAK2C0017638Glioma0.00300763924902685BEFREE;LHGDN
3717JAK2C0678222Breast Carcinoma0.002747267842131BEFREE
3717JAK2C0020517Hypersensitivity0.00273291246481375LHGDN
3717JAK2C0003130Anoxia0.00273291246481375LHGDN
3717JAK2C0008497Choriocarcinoma0.00273291246481375LHGDN
3717JAK2C0009375Colonic Neoplasms0.00273291246481375LHGDN
3717JAK2C0024314Lymphoproliferative Disorders0.0026817553075011BEFREE;GAD
3717JAK2C0026769Multiple Sclerosis0.0026817553075011BEFREE;GAD
3717JAK2C0028754Obesity0.0026817553075011BEFREE;GAD
3717JAK2C0041107Trisomy0.0026817553075011BEFREE;GAD
3717JAK2C0021655Insulin Resistance0.002407028523288GAD
3717JAK2C0033027Preleukemia0.002407028523288GAD
3717JAK2C0034065Pulmonary Embolism0.002407028523288GAD
3717JAK2C0035235Respiratory Syncytial Virus Infections0.002407028523288GAD
3717JAK2C0040336Tobacco Use Disorder0.002407028523288GAD
3717JAK2C0040715Chromosomal translocation0.002407028523288GAD
3717JAK2C0042749Viremia0.002407028523288GAD
3717JAK2C0149871Deep Vein Thrombosis0.002407028523288GAD
3717JAK2C0162316Iron deficiency anemia0.002407028523288GAD
3717JAK2C0524909Hepatitis B, Chronic0.002407028523288GAD
3717JAK2C0003838Arterial Occlusive Diseases0.002407028523288GAD
3717JAK2C0004096Asthma0.002407028523288GAD
3717JAK2C0006274Bronchiolitis, Viral0.002407028523288GAD
3717JAK2C0008625Chromosome Aberrations0.002407028523288GAD
3717JAK2C0012860DNA Damage0.002407028523288GAD
3717JAK2C1527405Erythrocytosis0.002407028523288GAD
3717JAK2C0019080Hemorrhage0.002407028523288GAD
3717JAK2C0024623Malignant neoplasm of stomach0.0021978142737048BEFREE
3717JAK2C0699791Stomach Carcinoma0.0021978142737048BEFREE
3717JAK2C0019154Hepatic Vein Thrombosis0.0021978142737048BEFREE
3717JAK2C0242596Neoplasm, Residual0.0019230874894917BEFREE
3717JAK2C0002871Anemia0.0019230874894917BEFREE
3717JAK2C0039240Supraventricular tachycardia0.0016483607052786BEFREE
3717JAK2C0242006Myelofibrosis due to another disorder0.0016483607052786BEFREE
3717JAK2C0376358Malignant neoplasm of prostate0.0016483607052786BEFREE
3717JAK2C0600139Prostate carcinoma0.0016483607052786BEFREE
3717JAK2C0009812Constitutional Symptom0.0016483607052786BEFREE
3717JAK2C0018939Hematological Disease0.0016483607052786BEFREE
3717JAK2C0424295Hyperactive behavior0.0013736339210655BEFREE
3717JAK2C0596263Carcinogenesis0.0013736339210655BEFREE
3717JAK2C0598766Leukemogenesis0.0013736339210655BEFREE
3717JAK2C0007131Non-Small Cell Lung Carcinoma0.0013736339210655BEFREE
3717JAK2C1264195Refractory anemia with ringed sideroblasts0.0013736339210655BEFREE
3717JAK2C1306759Eosinophilic disorder0.0013736339210655BEFREE
3717JAK2C0009402Colorectal Carcinoma0.0013736339210655BEFREE
3717JAK2C1318533Secondary polycythemia0.0013736339210655BEFREE
3717JAK2C1527249Colorectal Cancer0.0013736339210655BEFREE
3717JAK2C0023462Acute Megakaryocytic Leukemias0.0010989071368524BEFREE
3717JAK2C0023481Chronic Neutrophilic Leukemia0.0010989071368524BEFREE
3717JAK2C0027013Myeloid Metaplasia0.0010989071368524BEFREE
3717JAK2C0079744Diffuse Large B-Cell Lymphoma0.0010989071368524BEFREE
3717JAK2C0152264Familial erythrocytosis0.0010989071368524BEFREE
3717JAK2C0684249Carcinoma of lung0.0010989071368524BEFREE
3717JAK2C0004364Autoimmune Diseases0.0010989071368524BEFREE
3717JAK2C1333064Classical Hodgkin's Lymphoma0.0010989071368524BEFREE
3717JAK2C0014457Eosinophilia0.0010989071368524BEFREE
3717JAK2C1961099Precursor T-Cell Lymphoblastic Leukemia-Lymphoma0.0010989071368524BEFREE
3717JAK2C2239176Liver carcinoma0.0010989071368524BEFREE
3717JAK2C2826330Refractory anemia with ring sideroblasts associated with marked thrombocytosis0.0008241803526393BEFREE
3717JAK2C2939461Myeloid neoplasm0.0008241803526393BEFREE
3717JAK2C0023448Lymphoid leukemia0.0008241803526393BEFREE
3717JAK2C0023492Leukemia, T-Cell0.0008241803526393BEFREE
3717JAK2C0027627Neoplasm Metastasis0.0008241803526393BEFREE
3717JAK2C0029925Ovarian Carcinoma0.0008241803526393BEFREE
3717JAK2C0155773Portal vein thrombosis0.0008241803526393BEFREE
3717JAK2C0242379Malignant neoplasm of lung0.0008241803526393BEFREE
3717JAK2C0332996Persistent embryonic structure0.0008241803526393BEFREE
3717JAK2C0376544Hematopoietic Neoplasms0.0008241803526393BEFREE
3717JAK2C0699790Colon Carcinoma0.0008241803526393BEFREE
3717JAK2C0007102Malignant tumor of colon0.0008241803526393BEFREE
3717JAK2C1292754Mediastinal (Thymic) Large B-Cell Lymphoma0.0008241803526393BEFREE
3717JAK2C1306460Primary malignant neoplasm of lung0.0008241803526393BEFREE
3717JAK2C2827469Coronary Microvascular Disease0.0005494535684262BEFREE
3717JAK2C3203102Idiopathic pulmonary arterial hypertension0.0005494535684262BEFREE
3717JAK2C0023452Leukemia, Lymphocytic, Acute, L10.0005494535684262BEFREE
3717JAK2C3539878Triple Negative Breast Neoplasms0.0005494535684262BEFREE
3717JAK2C3665444Neutrophilia (disorder)0.0005494535684262BEFREE
3717JAK2C0085702Monocytosis0.0005494535684262BEFREE
3717JAK2C0149925Small cell carcinoma of lung0.0005494535684262BEFREE
3717JAK2C0151945Thrombosis of cerebral veins0.0005494535684262BEFREE
3717JAK2C0178874Tumor Progression0.0005494535684262BEFREE
3717JAK2C0206141Idiopathic Hypereosinophilic Syndrome0.0005494535684262BEFREE
3717JAK2C0235974Pancreatic carcinoma0.0005494535684262BEFREE
3717JAK2C0280100solid tumor0.0005494535684262BEFREE
3717JAK2C0280449secondary acute myeloid leukemia0.0005494535684262BEFREE
3717JAK2C0346421Chronic eosinophilic leukemia0.0005494535684262BEFREE
3717JAK2C0346647Malignant neoplasm of pancreas0.0005494535684262BEFREE
3717JAK2C0584960Factor V Leiden mutation0.0005494535684262BEFREE
3717JAK2C0002395Alzheimer's Disease0.0005494535684262BEFREE
3717JAK2C0745091Hypereosinophilia0.0005494535684262BEFREE
3717JAK2C1140680Malignant neoplasm of ovary0.0005494535684262BEFREE
3717JAK2C1292779Myelodysplastic Syndrome with Isolated del(5q)0.0005494535684262BEFREE
3717JAK2C0010054Coronary Arteriosclerosis0.0005494535684262BEFREE
3717JAK2C1512981Mammary Tumorigenesis0.0005494535684262BEFREE
3717JAK2C0014122Subacute Bacterial Endocarditis0.0005494535684262BEFREE
3717JAK2C1621958Glioblastoma Multiforme0.0005494535684262BEFREE
3717JAK2C0017636Glioblastoma0.0005494535684262BEFREE
3717JAK2C1852502CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT0.0005494535684262BEFREE
3717JAK2C1861922CAMPOMELIC DYSPLASIA0.0005494535684262BEFREE
3717JAK2C2613439Extramedullary Hematopoiesis (disorder)0.0005494535684262BEFREE
3717JAK2C2827356Myeloid and Lymphoid Neoplasms with Eosinophilia and Abnormalities of PDGFRA, PDGFRB, or FGFR10.0002747267842131BEFREE
3717JAK2C0021051Immunologic Deficiency Syndromes0.0002747267842131BEFREE
3717JAK2C2931822Nasopharyngeal carcinoma0.0002747267842131BEFREE
3717JAK2C2981142Refractory anemia, without ringed sideroblasts, without excess blasts0.0002747267842131BEFREE
3717JAK2C3469521FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder)0.0002747267842131BEFREE
3717JAK2C3839741Core binding factor acute myeloid leukemia0.0002747267842131BEFREE
3717JAK2C3839868Cytogenetically normal acute myeloid leukemia0.0002747267842131BEFREE
3717JAK2C3853548Pdgfra-Associated Chronic Eosinophilic Leukemia0.0002747267842131BEFREE
3717JAK2C0023487Acute Promyelocytic Leukemia0.0002747267842131BEFREE
3717JAK2C0023493Adult T-Cell Lymphoma/Leukemia0.0002747267842131BEFREE
3717JAK2C4048328cervical cancer0.0002747267842131BEFREE
3717JAK2C4049883Obstructive Ureterocele0.0002747267842131BEFREE
3717JAK2C4054188Ph-Like Acute Lymphoblastic Leukemia0.0002747267842131BEFREE
3717JAK2C4273671Inherited predisposition to essential thrombocythemia0.0002747267842131BEFREE
3717JAK2C4274414Epstein-Barr virus associated gastric carcinoma0.0002747267842131BEFREE
3717JAK2C0024121Lung Neoplasms0.0002747267842131BEFREE
3717JAK2C0024899Mastocytosis0.0002747267842131BEFREE
3717JAK2C0025167Megakaryocytic hyperplasia0.0002747267842131BEFREE
3717JAK2C0025286Meningioma0.0002747267842131BEFREE
3717JAK2C0026277Mixed Salivary Gland Tumor0.0002747267842131BEFREE
3717JAK2C0026985Myelodysplasia0.0002747267842131BEFREE
3717JAK2C0027819Neuroblastoma0.0002747267842131BEFREE
3717JAK2C0027831Neurofibromatosis 10.0002747267842131BEFREE
3717JAK2C0031069Familial Mediterranean Fever0.0002747267842131BEFREE
3717JAK2C0033860Psoriasis0.0002747267842131BEFREE
3717JAK2C0035328Retinal Vein Occlusion0.0002747267842131BEFREE
3717JAK2C0036572Seizures0.0002747267842131BEFREE
3717JAK2C0036920Sezary Syndrome0.0002747267842131BEFREE
3717JAK2C0037274Dermatologic disorders0.0002747267842131BEFREE
3717JAK2C0039730Thalassemia0.0002747267842131BEFREE
3717JAK2C0040100Thymoma0.0002747267842131BEFREE
3717JAK2C0042170Uveomeningoencephalitic Syndrome0.0002747267842131BEFREE
3717JAK2C0079748Precursor cell lymphoblastic lymphoma0.0002747267842131BEFREE
3717JAK2C0079772T-Cell Lymphoma0.0002747267842131BEFREE
3717JAK2C0079773Lymphoma, T-Cell, Cutaneous0.0002747267842131BEFREE
3717JAK2C0085096Peripheral Vascular Diseases0.0002747267842131BEFREE
3717JAK2C0085110Severe Combined Immunodeficiency0.0002747267842131BEFREE
3717JAK2C0152013Adenocarcinoma of lung (disorder)0.0002747267842131BEFREE
3717JAK2C0152276Granulocytic Sarcoma0.0002747267842131BEFREE
3717JAK2C0153381Malignant neoplasm of mouth0.0002747267842131BEFREE
3717JAK2C0153594Malignant neoplasm of testis0.0002747267842131BEFREE
3717JAK2C0175703Thrombocytopenia-Absent Radius Syndrome0.0002747267842131BEFREE
3717JAK2C0206138CREST Syndrome0.0002747267842131BEFREE
3717JAK2C0220641Lip and Oral Cavity Carcinoma0.0002747267842131BEFREE
3717JAK2C0240912Vertical Talus0.0002747267842131BEFREE
3717JAK2C0241868acute aortic dissection0.0002747267842131BEFREE
3717JAK2C0242621Isochromosomes0.0002747267842131BEFREE
3717JAK2C0263662Disseminated eosinophilic collagen disease0.0002747267842131BEFREE
3717JAK2C0278883Metastatic melanoma0.0002747267842131BEFREE
3717JAK2C0279549Philadelphia chromosome negative chronic myelogenous leukemia0.0002747267842131BEFREE
3717JAK2C0279583T-cell childhood acute lymphoblastic leukemia0.0002747267842131BEFREE
3717JAK2C0279628Adenocarcinoma Of Esophagus0.0002747267842131BEFREE
3717JAK2C0279651Gallbladder adenocarcinoma0.0002747267842131BEFREE
3717JAK2C0302592Cervix carcinoma0.0002747267842131BEFREE
3717JAK2C0340987Splenic atrophy0.0002747267842131BEFREE
3717JAK2C0344460Carcinoma ex pleomorphic adenoma0.0002747267842131BEFREE
3717JAK2C0346153Breast Cancer, Familial0.0002747267842131BEFREE
3717JAK2C0349532Gastric lymphoma0.0002747267842131BEFREE
3717JAK2C0374997Helicobacter pylori (H. pylori) infection in conditions classified elsewhere and of unspecified site0.0002747267842131BEFREE
3717JAK2C0410000Overlap syndrome0.0002747267842131BEFREE
3717JAK2C0432411Chromosome 9, trisomy0.0002747267842131BEFREE
3717JAK2C0432412Chromosome 8, trisomy0.0002747267842131BEFREE
3717JAK2C0457506Reactive thrombocytosis0.0002747267842131BEFREE
3717JAK2C0546837Malignant neoplasm of esophagus0.0002747267842131BEFREE
3717JAK2C0578575Proximal aortic dissection0.0002747267842131BEFREE
3717JAK2C0600502Vascular Hemostatic Disorders0.0002747267842131BEFREE
3717JAK2C0677886Epithelial ovarian cancer0.0002747267842131BEFREE
3717JAK2C0001339Acute pancreatitis0.0002747267842131BEFREE
3717JAK2C0002890Leukoerythroblastic Anemia0.0002747267842131BEFREE
3717JAK2C0700095Central neuroblastoma0.0002747267842131BEFREE
3717JAK2C07403025q-syndrome0.0002747267842131BEFREE
3717JAK2C0740394Hyperuricemia0.0002747267842131BEFREE
3717JAK2C0740992anemia hemoglobin0.0002747267842131BEFREE
3717JAK2C0003850Arteriosclerosis0.0002747267842131BEFREE
3717JAK2C0003864Arthritis0.0002747267842131BEFREE
3717JAK2C0850666helicobacter pylori infection0.0002747267842131BEFREE
3717JAK2C0855197Testicular malignant germ cell tumor0.0002747267842131BEFREE
3717JAK2C0004114Astrocytoma0.0002747267842131BEFREE
3717JAK2C0856825Acute GVH disease0.0002747267842131BEFREE
3717JAK2C0004943Behcet Syndrome0.0002747267842131BEFREE
3717JAK2C0005779Blood Coagulation Disorders0.0002747267842131BEFREE
3717JAK2C0006118Brain Neoplasms0.0002747267842131BEFREE
3717JAK2C0948089Acute Coronary Syndrome0.0002747267842131BEFREE
3717JAK2C1168401Squamous cell carcinoma of the head and neck0.0002747267842131BEFREE
3717JAK2C0007137Squamous cell carcinoma0.0002747267842131BEFREE
3717JAK2C1279296Chronic leukemia (category)0.0002747267842131BEFREE
3717JAK2C1282609Granulocytosis0.0002747267842131BEFREE
3717JAK2C1292758Precursor T-cell lymphoblastic lymphoma0.0002747267842131BEFREE
3717JAK2C0007847Malignant tumor of cervix0.0002747267842131BEFREE
3717JAK2C0008626Congenital chromosomal disease0.0002747267842131BEFREE
3717JAK2C1301355Myelodysplastic-Myeloproliferative Diseases0.0002747267842131BEFREE
3717JAK2C1328061Myelodysplastic/myeloproliferative neoplasm, unclassifiable0.0002747267842131BEFREE
3717JAK2C1332977Childhood Leukemia0.0002747267842131BEFREE
3717JAK2C0011854Diabetes Mellitus, Insulin-Dependent0.0002747267842131BEFREE
3717JAK2C0011860Diabetes Mellitus, Non-Insulin-Dependent0.0002747267842131BEFREE
3717JAK2C1334665Mediastinal Lymphoma0.0002747267842131BEFREE
3717JAK2C1334968Nodular Lymphocyte Predominant Hodgkin Lymphoma0.0002747267842131BEFREE
3717JAK2C1519670Tumor Angiogenesis0.0002747267842131BEFREE
3717JAK2C1521897Mature T ALL0.0002747267842131BEFREE
3717JAK2C0014474Ependymoma0.0002747267842131BEFREE
3717JAK2C1540912Hypereosinophilic syndrome0.0002747267842131BEFREE
3717JAK2C0015625Fanconi Anemia0.0002747267842131BEFREE
3717JAK2C1704272Benign Prostatic Hyperplasia0.0002747267842131BEFREE
3717JAK2C1704436Peripheral Arterial Diseases0.0002747267842131BEFREE
3717JAK2C1709246Non-Neoplastic Disorder0.0002747267842131BEFREE
3717JAK2C1802398Chromosome 5, trisomy 5q0.0002747267842131BEFREE
3717JAK2C0017925Glycogen Storage Disease Type VI0.0002747267842131BEFREE
3717JAK2C0018133Graft-vs-Host Disease0.0002747267842131BEFREE
3717JAK2C0018553Hamartoma Syndrome, Multiple0.0002747267842131BEFREE
3717JAK2C1868682Paroxysmal kinesigenic choreoathetosis0.0002747267842131BEFREE
3717JAK2C1960397Philadelphia chromosome-positive acute lymphoblastic leukemia0.0002747267842131BEFREE
3717JAK2C2004493Leukemia, B-Cell0.0002747267842131BEFREE
3717JAK2C0020456Hyperglycemia0.0002747267842131BEFREE
3717JAK2C2698259Monoclonal B-Cell Lymphocytosis0.0002747267842131BEFREE
3717JAK2C0020459Hyperinsulinism0.0002747267842131BEFREE
3717JAK2C2745900Promyelocytic leukemia0.0002747267842131BEFREE